Polypharmacy and sarcopenia in hospitalized older patients: results of the GLISTEN study.
CONCLUSIONS: Present findings demonstrate that the association of polypharmacy with sarcopenia, observed in the BASE-II study, is not evident in the GLISTEN sample, being our patients significantly older, more multi-morbid, with high prevalence of sarcopenia and polypharmacy, suggesting that this association might vary according to the heterogeneous health, functional, and nutritional characteristics of older people.
PMID: 30778874 [PubMed - as supplied by publisher]
Source: Aging Clinical and Experimental Research - Category: Geriatrics Authors: Agosta L, Bo M, Bianchi L, Abete P, Belelli G, Cherubini A, Corica F, Di Bari M, Maggio M, Manca GM, Rizzo MR, Rossi A, Landi F, Volpato S, GLISTEN Group Investigators Tags: Aging Clin Exp Res Source Type: research